Clinical Trials on Bortezomib

Total 7 results

Zhongnan Hospital

Recruiting

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

Acute Myeloid Leukemia | Bortezomib

China
Ruijin Hospital

Recruiting

Bortezomib for Treating Glomerular Diseases

Glomerulonephritis | IgA Nephropathy | FSGS | Bortezomib | MN | MPGN

China
Beijing Chao Yang Hospital

Enrolling by invitation

Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics

Multiple Myeloma | Bortezomib

China
Second Affiliated Hospital of Soochow University

Unknown

Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma

Myeloma | Dexamethasone | Granulocyte Colony-Stimulating Factor | Cyclophosphamide | Bortezomib

China
University Hospital, Clermont-Ferrand
Laboratoires Takeda

Unknown

Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple (SENSIB)

Multiple Myeloma | Adult | Bortezomib Regimen

France
Novartis Pharmaceuticals

Completed

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma (MACS1271)

Refractory Multiple Myeloma | Multiple Myeloma in Relapse | Relapsed and Bortezomib Refractory Multiple Myeloma

United States
National University Hospital, Singapore
Celgene

Unknown

Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib

Multiple Myeloma | Relapse After Use of Lenalidomide and Bortezomib

Singapore

3

Subscribe